Jiawei Danzhong Powder Veterinary Grade API is incorporated into tablet cores only after a batch-specific flow and moisture audit because the as-supplied botanical powder exhibits variable hygroscopicity above 55% RH. A direct-compression line using a 20 kN compression force on a 16-station rotary press can maintain hardness between 40 N and 70 N if the granulate moisture is clamped at 3.0–4.5% by Karl Fischer titration (Ph. Eur. 2.5.12) and the lubricant blending time does not exceed 5 min. The core formulation is designed around an active loading of 35–50 wt%; microcrystalline cellulose is added at 20–35 wt% to absorb shear stress, partially pregelatinized starch at 8–15 wt% as binder, croscarmellose sodium at 3–5 wt% as disintegrant, and magnesium stearate at 0.5–1.0 wt% as lubricant. Granulation is triggered when the powder's angle of repose exceeds 40° or the fines fraction below 75 µm is above 30%; a top-spray fluid bed with inlet air at 55–60 °C and an LOD endpoint of 3.5–4.5% yields a granulate with a bulk density of 0.50–0.65 g/cm³. Compression is stopped if ejection stress rises above 10 MPa or if capping occurs on tablets with tensile strength below 1.5 MPa. Film coating with a 12% w/w aqueous Opadry system is applied to 3–4% weight gain in a 36-inch pan at 45 °C bed temperature. Release tests follow the Chinese Veterinary Pharmacopoeia tablet monograph for weight variation, disintegration time in water at 37 °C not exceeding 30 min, and content uniformity with an acceptance value not exceeding 15.

Pyrogen and Particulate Control in Parenteral Jiawei Danzhong Preparations

Preparation of an injectable dosage form from Jiawei Danzhong Powder requires deionized water-for-injection with conductivity not exceeding 1.3 µS/cm at 25 °C and bacterial endotoxin below 0.25 EU/mL. A concentrated aqueous extract is prepared by suspending the API in WFI at 40–60 mg/mL total solids and passing it through a 0.45 µm polyethersulfone clarifying filter; the filter may load rapidly if the powder contains non-extractable fiber, so a disposable depth filter with a nominal retention of 1 µm is placed upstream. Sterilizing filtration through a 0.22 µm PVDF membrane is performed under EU GMP Annex 1 aseptic conditions, with filter integrity tested by bubble point before and after filling. Terminal sterilization at 121 °C for 15 min is permissible only when forced degradation data demonstrate marker loss below 5%; otherwise the batch is filled aseptically into 10 mL type I borosilicate vials and stoppered under ISO 14644-1:2015 Grade A laminar flow with a Grade B background. Sub-visible particulate matter is tested by light obscuration according to USP <788>, with limits of ≤ 6000 particles ≥10 µm and ≤ 600 particles ≥25 µm per container for small-volume parenterals. The formulation contains 10–20% v/v propylene glycol as a miscible cosolvent and is adjusted to pH 5.0–5.5 with citrate buffer, because pH above 6.5 accelerates oxidative browning of the phenolic fraction within 24 h at 40 °C. The injectable solution is incompatible with iron- or copper-containing silicone tubing; stainless steel 316L product-contact surfaces are acceptable only when passivated and cleaned without hypochlorite residues. Sterility is tested by membrane filtration per Chinese Veterinary Pharmacopoeia, and bacterial endotoxin by limulus amebocyte lysate at ≤ 0.5 EU/mg of active solids. Where published data for this specific botanical configuration is limited, the registration file must include a bracketed holding time study for the sterile filtered bulk at 2–8 °C not exceeding 24 h before filling.

What Changes in Fill Weight Variation When the Powder Is Encapsulated on a Tamping-Pin Machine?

Encapsulation of Jiawei Danzhong Powder on a tamping-pin machine is limited by the powder's compressibility and friction against the dosing disc; without a glidant the angle of repose often exceeds 40° and the Carr index rises above 25, producing capsule fill weight RSD above 4% at 60,000 capsules per hour. A free-flowing capsule blend is prepared by combining 45–60 wt% Jiawei Danzhong Powder, 35–50 wt% pregelatinized maize starch, 2–5 wt% colloidal silicon dioxide, and 0.5–1.0 wt% sodium stearyl fumarate. The glidant and powder are premilled through a 0.8 mm conical screen with a rotor speed of 1500 rpm before blending in a bin blender at 12 rpm for 20–25 min; lubrication longer than 30 min decreases hardness and delays capsule disintegration in water beyond 30 min at 37 °C. Size 0 hard gelatin capsules are filled to a target gross fill weight of 350–450 mg, with the tamping station set to 3–5 tamping cycles and compression force limited to 80 N; higher force compacts the botanical powder into a slug that does not break, leaving an under-filled capsule. The finished capsules are inspected for fill weight every 15 min using a weight sorting checkweigher with a reject limit of ± 3.0% around the target. Disintegration testing follows the capsule monograph of the current Chinese Veterinary Pharmacopoeia; content uniformity is tested on 10 units at start, middle, and end of the filling run, with an acceptance value not more than 15. The shell is conditioned at 40–50% RH because botanical powder containing residual moisture above 5.0% causes softening and dimpling of gelatin; HPMC capsules are substituted when low-moisture storage is required.

Dry powders for oral administration in drinking water or on feed require a particle-size distribution that excludes both large granules and deeply respirable fines. Jiawei Danzhong Powder is milled through a 1.0 mm oscillating sieve and blended with anhydrous dextrose or lactose monohydrate to an active powder fraction of 10–25 wt%; below 10 wt%, the segregation risk in vertical form-fill-seal equipment increases and sampling per batch must follow a stratified plan across 10 fill stations. A light mineral oil is sprayed at 0.3–0.5 wt% onto the moving powder bed to suppress dust while maintaining flow into the dosing auger; excessive oil above 1.0 wt% creates agglomerates and blocks the sieve screen. The powder is filled into aluminium foil laminate sachets with a moisture vapor transmission rate below 0.5 g/m²/day at 38 °C / 90% RH to keep the botanical matrix below 5.0% moisture. The batch is rejected if the content uniformity acceptance value exceeds 15 or if any of 10 individual samples falls outside 90–110% of the declared marker content. The powder format is used for direct addition to drinking water at a final concentration of 0.5–1.0 g/L, but the actual use rate is derived from the registered dose per kg bodyweight and is not adjusted without a veterinarian-approved change control.

Wet Granulation Variables When Targeting Oral Granules for Poultry Drinking Water

Jiawei Danzhong Powder is converted into dispersible granules in a high-shear granulator with an impeller speed of 150–250 rpm and a chopper at 1000–1500 rpm. A binder solution of povidone K30 at 3–6 wt% of the dry blend is prepared in 50:50 v/v ethanol-water to reduce hydration of the botanical powder; adding water alone can produce a cohesive mass that overloads the granulator drive within 60 s. The dry blend contains 5–10 wt% Jiawei Danzhong Powder as active concentrate, 30–50 wt% lactose monohydrate or maltodextrin as diluent, and 5–15 wt% sucrose milled through a 0.5 mm screen as a palatability carrier; the active dilution is selected so that 1 g of final granules delivers the target dose for 1 L of drinking water when applied through a poultry proportioner. The wet mass endpoint is determined by impeller power consumption and not only by visual appearance; the load should rise by 10–20% from the dry mix baseline, and the granulation time after binder addition should not exceed 4–6 min. Fluid-bed drying with inlet air at 55–60 °C brings the moisture to 3.0–4.5%; granules dried below 2.5% lose cohesion and generate fines, while granules above 5.5% become tacky in storage. The dried granules are screened through 500 µm and 100 µm sieves per ASTM E11; not more than 5% is retained on 500 µm, and not more than 10% passes 100 µm. Dispersion in water at 25 °C is checked by stirring 1 g in 100 mL for 60 s; not more than 5% of the granule mass should remain on a 250 µm wet sieve after 2 min. The granulation process is considered failed if batch foaming occurs during dispersion, which indicates excess povidone or incomplete drying.

When Jiawei Danzhong Powder Is Diluted for Medicated Feed Premix

Medicated feed premix operations treat Jiawei Danzhong Powder as a concentrated botanical ingredient that must be stepwise diluted before it is added to a final feed mixer. A typical working dilution is 1:50 with rice hull or ground maize carrier, but the registered premix ratio is established from the target in-feed inclusion and the assay of the active marker. The premix is manufactured in a horizontal ribbon mixer at 50–70% working volume; the active powder is first mixed with an equal mass of carrier for 5 min, then the remaining carrier is added and mixed for 15–20 min. Sampling uses a grain thief at 10 points distributed across the mixer discharge; the coefficient of variation for the marker compound by HPLC must be ≤ 5%, and individual values must fall between 90% and 110% of the declaration. Carrier selection changes the mixing dynamics: rice hull improves flow and reduces caking, but it may segregate from the API if its bulk density differs by more than 0.2 g/cm³; ground maize reduces segregation but supports mold growth above 14% moisture. The finished premix is packed in 25 kg multi-wall bags with an inner polyethylene liner and stored below 25 °C and 60% RH. In the United States, a medicated feed containing this API would be subject to veterinary feed directive procedures under 21 CFR 558 only if the product is approved for feed use; otherwise the premix is limited to on-label oral solutions or powders. The premix is rejected if the analytical sample shows mycotoxic or heavy-metal contamination exceeding the registered limit or if the moisture content exceeds 5.0%.

Oral solutions for mass medication in drinking water are prepared by dispersing Jiawei Danzhong Powder in purified water with 10–20% v/v propylene glycol or glycerin as a cosolvent; without the cosolvent, the botanical powder settles as a sediment within 30 min even after high-shear mixing. The batch is adjusted to pH 4.5–5.5 using 0.1 M citrate buffer; above pH 6.5, the phenolic fraction darkens and marker loss accelerates at 40 °C within 24 h. If the solution is filled into multi-dose containers, sodium benzoate at 0.1% w/v and potassium sorbate at 0.1% w/v are added as preservatives; preservative efficacy is tested according to USP <51>, and the container closure must be challenged for microbial ingress. The solution is filtered through a 10 µm polypropylene depth filter and then a 1 µm retention filter before filling into high-density polyethylene jugs; residual air in the headspace is reduced by nitrogen flushing if oxidative stability data require it. Finished product is stored under accelerated conditions at 40 °C ± 2 °C / 75% RH ± 5% for 6 months per VICH GL3; a batch is placed on long-term stability at 25 °C ± 2 °C / 60% RH ± 5%. Dosing on farm is usually through a proportioner set at 1% or 2% of drinking water, but the final dilution is always calculated from the registered mg/kg bodyweight dose and the daily water consumption of the flock. If the solution is intended for injection rather than oral use, the formulation must meet the stricter pyrogen and particulate controls described for parenteral preparation; oral solutions must not be substituted into injection lines without sterility and endotoxin verification.